Redhill Biopharma Ltd (RDHL.OQ)

RDHL.OQ on NASDAQ Stock Exchange Capital Market

15.06USD
30 Jan 2015
Change (% chg)

$-0.44 (-2.84%)
Prev Close
$15.50
Open
$15.25
Day's High
$15.25
Day's Low
$15.06
Volume
643
Avg. Vol
7,311
52-wk High
$20.00
52-wk Low
$7.80

RDHL.OQ

Chart for RDHL.OQ

About

RedHill Biopharma Ltd. (RedHill) is an Israeli biopharmaceutical company focused on the development and acquisition of late clinical-stage, drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestinal cancers. The Company’s pipeline of products includes RHB-104, RHB-105, RHB-102, RHB-106,... (more)

Overall

No Ratios Available.

Financials

  RDHL.OQ Industry Sector
P/E (TTM): -- 188.86 38.54
EPS (TTM): -- -- --
ROI: -- -1.23 18.06
ROE: -- -3.07 18.83
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: ValuEngine, Inc.
$49.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks